ClearPoint Neuro
CLPT • NASDAQ
ClearPoint Neuro is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Joseph Michael Burnett, with a market cap of $269.1M.
Market Cap$269.1M
Employees107.0
CEOJoseph Michael Burnett
CountryUnited States of America
Healthcare
Medical - Devices
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
ClearPoint Neuro FAQ
Common questions about ClearPoint Neuro
ClearPoint Neuro is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $12.2M.
ClearPoint Neuro has approximately 107 employees.